2025-2031 Global Diphtheria Tetanus Pertussis Vaccine Industry Research & Trends Analysis Report- YH Research

Home > Reports >Pharma & Healthcare > 2025-2031 Global Diphtheria Tetanus Pertussis Vaccine Industry Research & Trends Analysis Report

2025-2031 Global Diphtheria Tetanus Pertussis Vaccine Industry Research & Trends Analysis Report

Publication Date: 2025-12-12
Report Id: 2862881
Industry: Pharma & Healthcare
Report Page: 129
Chart: 127

PDF Download

Publication Date: 2025-12-12
Report Id: 2862881
Industry: Pharma & Healthcare
Report Page: 129
Chart: 127

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Diphtheria Tetanus Pertussis Vaccine Definition
1.2 Global Diphtheria Tetanus Pertussis Vaccine Market Size and Forecast
1.2.1 By Revenue, Global Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
1.2.2 By Sales Volume, Global Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
1.2.3 Global Diphtheria Tetanus Pertussis Vaccine Price Trend, 2020-2031
1.3 China Diphtheria Tetanus Pertussis Vaccine Market Size and Forecast
1.3.1 By Revenue, China Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
1.3.2 By Sales Volume, China Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
1.3.3 China Diphtheria Tetanus Pertussis Vaccine Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Diphtheria Tetanus Pertussis Vaccine Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Diphtheria Tetanus Pertussis Vaccine Share in Global Market, 2020-2031
1.4.3 Diphtheria Tetanus Pertussis Vaccine Market Size: China VS Global, 2020-2031
1.5 Diphtheria Tetanus Pertussis Vaccine Market Dynamics
1.5.1 Diphtheria Tetanus Pertussis Vaccine Market Drivers
1.5.2 Diphtheria Tetanus Pertussis Vaccine Market Restraints
1.5.3 Diphtheria Tetanus Pertussis Vaccine Industry Trends
1.5.4 Diphtheria Tetanus Pertussis Vaccine Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Company, 2020-2025
2.2 Global Diphtheria Tetanus Pertussis Vaccine Sales Volume by Company, 2020-2025
2.3 Global Diphtheria Tetanus Pertussis Vaccine Price by Company, 2020-2025
2.4 Global Diphtheria Tetanus Pertussis Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Diphtheria Tetanus Pertussis Vaccine Concentration Ratio
2.6 Global Diphtheria Tetanus Pertussis Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Diphtheria Tetanus Pertussis Vaccine Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Diphtheria Tetanus Pertussis Vaccine Revenue by Company, 2020-2025
3.2 China Diphtheria Tetanus Pertussis Vaccine Sales Volume by Company, 2020-2025
3.3 China Diphtheria Tetanus Pertussis Vaccine Diphtheria Tetanus Pertussis Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Diphtheria Tetanus Pertussis Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Diphtheria Tetanus Pertussis Vaccine Domestic VS Export
3.6 China Market, Diphtheria Tetanus Pertussis Vaccine Import & Export
3.6.1 China Market, Diphtheria Tetanus Pertussis Vaccine Import & Export, 2020-2031
3.6.2 China Diphtheria Tetanus Pertussis Vaccine Import & Export Trends
3.6.3 Main Sources of China Diphtheria Tetanus Pertussis Vaccine Import
3.6.4 Export Destination of China Diphtheria Tetanus Pertussis Vaccine

4 Diphtheria Tetanus Pertussis Vaccine Production by Region
4.1 Global Diphtheria Tetanus Pertussis Vaccine Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Diphtheria Tetanus Pertussis Vaccine Manufacturers
4.3 Global Major Manufacturers, Diphtheria Tetanus Pertussis Vaccine Capacity Expansion and Future Plans
4.4 Global Diphtheria Tetanus Pertussis Vaccine Capacity by Region
4.5 Global Diphtheria Tetanus Pertussis Vaccine Production by Region
4.5.1 Global Diphtheria Tetanus Pertussis Vaccine Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Diphtheria Tetanus Pertussis Vaccine Production by Region, 2020-2025
4.5.3 Global Diphtheria Tetanus Pertussis Vaccine Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Diphtheria Tetanus Pertussis Vaccine Industry Chain
5.2 Diphtheria Tetanus Pertussis Vaccine Upstream Analysis
5.2.1 Diphtheria Tetanus Pertussis Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Diphtheria Tetanus Pertussis Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Diphtheria Tetanus Pertussis Vaccine Production Mode
5.6 Diphtheria Tetanus Pertussis Vaccine Procurement Model
5.7 Diphtheria Tetanus Pertussis Vaccine Industry Sales Model and Sales Channels
5.7.1 Diphtheria Tetanus Pertussis Vaccine Sales Model
5.7.2 Diphtheria Tetanus Pertussis Vaccine Typical Distributors

6 Sights by Type
6.1 Diphtheria Tetanus Pertussis Vaccine Classification by Type
6.1.1 DTaP
6.1.2 Tdap
6.1.3 DTwP
6.2 by Type, Global Diphtheria Tetanus Pertussis Vaccine Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2020-2031
6.4 by Type, Global Diphtheria Tetanus Pertussis Vaccine Sales Volume, 2020-2031
6.5 by Type, Global Diphtheria Tetanus Pertussis Vaccine Price, 2020-2031

7 Sights by Composition
7.1 Diphtheria Tetanus Pertussis Vaccine Classification by Composition
7.1.1 Acellular Vaccines
7.1.2 Whole-cell Vaccines
7.2 by Composition, Global Diphtheria Tetanus Pertussis Vaccine Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Composition, Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2020-2031
7.4 by Composition, Global Diphtheria Tetanus Pertussis Vaccine Sales Volume, 2020-2031
7.5 by Composition, Global Diphtheria Tetanus Pertussis Vaccine Price, 2020-2031

8 Sights by User
8.1 Diphtheria Tetanus Pertussis Vaccine Classification by User
8.1.1 Below 12 Months
8.1.2 Above 12 Months
8.2 by User, Global Diphtheria Tetanus Pertussis Vaccine Market Size & CAGR, 2020 VS 2024 VS 2031
8.3 by User, Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2020-2031
8.4 by User, Global Diphtheria Tetanus Pertussis Vaccine Sales Volume, 2020-2031
8.5 by User, Global Diphtheria Tetanus Pertussis Vaccine Price, 2020-2031

9 Sights by Application
9.1 Diphtheria Tetanus Pertussis Vaccine Segment by Application
9.1.1 Hospital
9.1.2 Clinic
9.2 by Application, Global Diphtheria Tetanus Pertussis Vaccine Market Size & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2020-2031
9.4 by Application, Global Diphtheria Tetanus Pertussis Vaccine Sales Volume, 2020-2031
9.5 by Application, Global Diphtheria Tetanus Pertussis Vaccine Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Diphtheria Tetanus Pertussis Vaccine Market Size, 2020 VS 2024 VS 2031
10.2 By Region, Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2020-2031
10.3 By Region, Global Diphtheria Tetanus Pertussis Vaccine Sales Volume, 2020-2031
10.4 North America
10.4.1 North America Diphtheria Tetanus Pertussis Vaccine Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Diphtheria Tetanus Pertussis Vaccine Market Size Market Share
10.5 Europe
10.5.1 Europe Diphtheria Tetanus Pertussis Vaccine Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Diphtheria Tetanus Pertussis Vaccine Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Diphtheria Tetanus Pertussis Vaccine Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Diphtheria Tetanus Pertussis Vaccine Market Size Market Share
10.7 South America
10.7.1 South AmericaDiphtheria Tetanus Pertussis Vaccine Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Diphtheria Tetanus Pertussis Vaccine Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Diphtheria Tetanus Pertussis Vaccine Market Size & CAGR，2020 VS 2024 VS 2031
11.2 By Country, Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2020-2031
11.3 By Country, Global Diphtheria Tetanus Pertussis Vaccine Sales Volume, 2020-2031
11.4 United States
11.4.1 United States Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
11.4.2 By Company, United States Diphtheria Tetanus Pertussis Vaccine Sales Volume Market Share, 2024
11.4.3 by Type, United States Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.4.4 by Application, United States Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
11.5.2 By Company, Europe Diphtheria Tetanus Pertussis Vaccine Sales Volume Market Share, 2024
11.5.3 by Type, Europe Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.5.4 by Application, Europe Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.6 China
11.6.1 China Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
11.6.2 By Company, China Diphtheria Tetanus Pertussis Vaccine Sales Volume Market Share, 2024
11.6.3 by Type, China Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.6.4 by Application, China Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
11.7.2 By Company, Japan Diphtheria Tetanus Pertussis Vaccine Market Share, 2024
11.7.3 by Type, Japan Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.7.4 by Application, Japan Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
11.8.2 By Company, South Korea Diphtheria Tetanus Pertussis Vaccine Market Share, 2024
11.8.3 by Type, South Korea Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.8.4 by Application, South Korea Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
11.9.2 By Company, Southeast Asia Diphtheria Tetanus Pertussis Vaccine Market Share, 2024
11.9.3 by Type, Southeast Asia Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.9.4 by Application, Southeast Asia Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.10 India
11.10.1 India Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
11.10.2 By Company, India Diphtheria Tetanus Pertussis Vaccine Market Share, 2024
11.10.3 by Type, India Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.10.4 by Application, India Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Market Size, 2020-2031
11.11.2 By Company, Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Market Share, 2024
11.11.3 by Type, Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031
11.11.4 by Application, Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Market Size, Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Company Information, Head Office, Market Area, and Industry Position
12.1.2 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Models, Specifications, and Application
12.1.3 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Sanofi Pasteur Company Profile and Main Business
12.1.5 Sanofi Pasteur Recent Developments
12.2 GSK
12.2.1 GSK Company Information, Head Office, Market Area, and Industry Position
12.2.2 GSK Diphtheria Tetanus Pertussis Vaccine Models, Specifications, and Application
12.2.3 GSK Diphtheria Tetanus Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.2.4 GSK Company Profile and Main Business
12.2.5 GSK Recent Developments
12.3 Mitsubishi Tanabe Pharma
12.3.1 Mitsubishi Tanabe Pharma Company Information, Head Office, Market Area, and Industry Position
12.3.2 Mitsubishi Tanabe Pharma Diphtheria Tetanus Pertussis Vaccine Models, Specifications, and Application
12.3.3 Mitsubishi Tanabe Pharma Diphtheria Tetanus Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Mitsubishi Tanabe Pharma Company Profile and Main Business
12.3.5 Mitsubishi Tanabe Pharma Recent Developments
12.4 KM Biologics
12.4.1 KM Biologics Company Information, Head Office, Market Area, and Industry Position
12.4.2 KM Biologics Diphtheria Tetanus Pertussis Vaccine Models, Specifications, and Application
12.4.3 KM Biologics Diphtheria Tetanus Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.4.4 KM Biologics Company Profile and Main Business
12.4.5 KM Biologics Recent Developments
12.5 Wuhan Institute of Biological Products
12.5.1 Wuhan Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
12.5.2 Wuhan Institute of Biological Products Diphtheria Tetanus Pertussis Vaccine Models, Specifications, and Application
12.5.3 Wuhan Institute of Biological Products Diphtheria Tetanus Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Wuhan Institute of Biological Products Company Profile and Main Business
12.5.5 Wuhan Institute of Biological Products Recent Developments
12.6 Walvax Biotechnology
12.6.1 Walvax Biotechnology Company Information, Head Office, Market Area, and Industry Position
12.6.2 Walvax Biotechnology Diphtheria Tetanus Pertussis Vaccine Models, Specifications, and Application
12.6.3 Walvax Biotechnology Diphtheria Tetanus Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.6.4 Walvax Biotechnology Company Profile and Main Business
12.6.5 Walvax Biotechnology Recent Developments
12.7 Chengdu Institute of Biological Products
12.7.1 Chengdu Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
12.7.2 Chengdu Institute of Biological Products Diphtheria Tetanus Pertussis Vaccine Models, Specifications, and Application
12.7.3 Chengdu Institute of Biological Products Diphtheria Tetanus Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Chengdu Institute of Biological Products Company Profile and Main Business
12.7.5 Chengdu Institute of Biological Products Recent Developments
12.8 Minhai Biotechnology
12.8.1 Minhai Biotechnology Company Information, Head Office, Market Area, and Industry Position
12.8.2 Minhai Biotechnology Diphtheria Tetanus Pertussis Vaccine Models, Specifications, and Application
12.8.3 Minhai Biotechnology Diphtheria Tetanus Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Minhai Biotechnology Company Profile and Main Business
12.8.5 Minhai Biotechnology Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Diphtheria Tetanus Pertussis Vaccine should grow from US$ 6131 million in 2024 to US$ 7698 million by 2031, with a CAGR of 3.3% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Diphtheria Tetanus Pertussis Vaccine

According to YH Research, the global market for Diphtheria Tetanus Pertussis Vaccine should grow from US$ 6131 million in 2024 to US$ 7698 million by 2031, with a CAGR of 3.3% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

In 2024, global Diphtheria Tetanus Pertussis Vaccine production reached approximately 350 million doses, with an average global market price of around US$ 16 per square meter. The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus. In this report, we cover all the DTP-containing vaccines. Gross margin for the Diphtheria Tetanus Pertussis Vaccine in general shows that manufacturers often achieve roughly 50–70% gross margins, depending on the producer, country, and contract.

The global Diphtheria Tetanus Pertussis Vaccine market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The Diphtheria Tetanus Pertussis Vaccine industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for Diphtheria Tetanus Pertussis Vaccines is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.

This report aims to provide a comprehensive study of the global market for Diphtheria Tetanus Pertussis Vaccine.
Report Highlights:
(1) Global Diphtheria Tetanus Pertussis Vaccine market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Diphtheria Tetanus Pertussis Vaccine market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Diphtheria Tetanus Pertussis Vaccine market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Diphtheria Tetanus Pertussis Vaccine segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Diphtheria Tetanus Pertussis Vaccine segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Diphtheria Tetanus Pertussis Vaccine, capacity, production and trends.

(7) Diphtheria Tetanus Pertussis Vaccine industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
DTaP
Tdap
DTwP

Market segment by Composition, covers
Acellular Vaccines
Whole-cell Vaccines

Market segment by User, covers
Below 12 Months
Above 12 Months

Market segment by Application, can be divided into
Hospital
Clinic

Market segment by players, this report covers
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology